Sign up to save your podcasts
Or
Share Peter Robinson and Justin Reese on Long COVID subtypes
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Peter Robinson and Justin Reese on Long COVID subtypes
Drs Robinson and Reese join eBioMedicine to discuss their findings on semantic phenotypic clustering long COVID subtypes observed in N3C and RECOVER programmes.
Read the full article:
Generalisable long COVID subtypes: findings from the NIH N3C and RECOVER programmes
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
View all episodes
By The Lancet GroupDrs Robinson and Reese join eBioMedicine to discuss their findings on semantic phenotypic clustering long COVID subtypes observed in N3C and RECOVER programmes.
Read the full article:
Generalisable long COVID subtypes: findings from the NIH N3C and RECOVER programmes
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
More shows like eBioMedicine in conversation with
View all
The Lancet Voice
21 Listeners
The Lancet Child & Adolescent Health in conversation with
0 Listeners
The Lancet Digital Health in conversation with
0 Listeners
The Lancet Global Health in conversation with
2 Listeners
The Lancet Oncology in conversation with
1 Listeners
The Lancet Psychiatry in conversation with
0 Listeners
The Lancet Respiratory Medicine in conversation with
2 Listeners
The Lancet in conversation with
0 Listeners
The Lancet Haematology in conversation with
0 Listeners
The Lancet Gastroenterology & Hepatology in conversation with
0 Listeners
The Lancet Diabetes & Endocrinology in conversation with
1 Listeners
The Lancet Infectious Diseases in conversation with
0 Listeners
The Lancet Public Health in conversation with
1 Listeners
The Lancet Microbe in conversation with
0 Listeners
In conversation with...
0 Listeners
The Lancet Rheumatology in conversation with
0 Listeners
The Lancet Regional Health in conversation with
0 Listeners
The Lancet Primary Care in conversation with
0 Listeners
The Lancet Regional Health Americas in conversation with
0 Listeners